Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dakshidin Corporatio (OP: DKSC )

0.0012 -0.0001 (-7.69%)
Streaming Delayed Price Updated: 2:05 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,353,853
Open 0.0012
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0013
Today's Range 0.0011 - 0.0013
52wk Range 0.0002 - 0.0017
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DKSC Engages ClearTrust as New Transfer Agent
SCOTTSDALE, Ariz. - Oct. 31, 2024 - PRLog -- Dakshidin Corporation (OTC:DKSC) is pleased to announce the engagement of ClearTrust, LLC as its new transfer agent. As DKSC advances in the fintech space,... 
Via PRLog
Dakshidin Corporation (OTC:DKSC), Signs an exclusive distribution deal with Stenergy LLC.
SAN FRANCISCO - Oct. 13, 2022 - PRLog -- Dakshidin Corporation (OTC:DKSC) has signed a distribution deal with one of the market's most exciting manufacturers of all-natural organic supplements.STENERGY... 
Via PRLog

Performance

YTD
+200.00%
+200.00%
1 Month
+71.43%
+71.43%
3 Month
+50.00%
+50.00%
6 Month
-7.69%
-7.69%
1 Year
+200.00%
+200.00%

More News

Read More
Dakshidin Corporation Marks Strategic Milestone with Stenergy LLC's IP Acquisition and COO Appointment
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
Whitechapel Announces Its Webinar Series - “Webinars for Living”
From Dakshidin Corporation
Via AccessWire
Dakshidin Corporation (OTC: DKSC) Relaunches Updated Whitechapelholdingsusa.com & Laughingfrogs.com Websites
From Dakshidin Corporation
Via AccessWire
Whitechapel Holdings, a Wholly-Owned Subsidiary of Dakshidin Corporation (OTC:DKSC), Signs an Exclusive Distribution Deal with BioSea Health
From Dakshidin Corporation
Via AccessWire
Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential
From Dakshidin Corporation
Via AccessWire
Dakshidin Corporation Signs Business Development Deal With Cicero Media Group
From Dakshidin Corporation
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.